Podcasts about Antimicrobial stewardship

Sepsis and bloodstream infections (BSIs) are common and cause millions of deaths each year, with a disproportionate burden in low-income and middle-income countries. Tune in to learn from Jasmine R. Marcelin, MD, FACP, FIDSA, how inadequate antibiotic coverage can be linked to increased mortality and length of stay and how unnecessary broad-spectrum antibiotics can drive antimicrobial resistance. Topics covered include:The worldwide burden of sepsis and BSIsThe ongoing threat of antimicrobial resistanceUS and global health disparities in sepsis, BSI, and antimicrobial resistanceBarriers toward optimizing antibiotic use in BSIsPresenter:Jasmine R. Marcelin, MD, FACP, FIDSAAssociate Professor, Infectious DiseaseAssociate Medical Director, Antimicrobial Stewardship ProgramVice Chair for Belonging and Community Engagement, Department of Internal MedicineCo-Director, Digital Innovation & Social Media Strategy, Division of Infectious DiseasesUniversity of Nebraska Medical CenterOmaha, NebraskaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Unnecessary broad-spectrum antibiotics can drive antimicrobial resistance and cause adverse events, whereas inadequate antibiotic coverage is linked to increased mortality and length of stay for patients with bloodstream infections (BSIs). Listen now to learn from Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP), how to use rapid genotypic and phenotypic antimicrobial susceptibility testing results to inform antibiotic selection for patients with gram-negative BSIs. Topics covered include:Typical patterns of intrinsic antibiotic susceptibility and resistance in EnterobacteralesMechanisms of resistance in gram-negative bacteriaGenotypic rapid diagnostic tests for BSIsResistance markers for earlier targeted therapyRapid phenotypic antimicrobial susceptibility test platforms for blood culturesPresenter:Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP)Medical and Public Health MicrobiologistMedical and Technical Director of MicrobiologyAdventHealthOrlando, FloridaLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Rapid phenotypic antimicrobial susceptibility testing (AST) significantly reduces time to actionable results and can improve antibiotic decision-making for patients with bloodstream infections. Listen in to learn from Michael P. Veve, PharmD, MPH, how to optimally integrate rapid phenotypic AST into clinical practice, including incorporation into your existing antimicrobial stewardship workflow. Topics covered include:Considerations for implementationDecision-making steps for implementationThe role of antimicrobial stewardship programs in AST workflowPresenter:Michael P. Veve, PharmD, MPHClinical Associate ProfessorDepartment of Pharmacy PracticeEugene Applebaum College of Pharmacy and Health SciencesWayne State UniversityClinical Pharmacy Specialist, Infectious DiseaseHenry Ford HospitalDetroit, MichiganLink to full program and downloadable slides:https://bit.ly/4inoXCxGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Exploring the antimicrobial properties of honey for wounds and synovial structures.Read the full article here: https://equimanagement.com/research-medical/treatments-medications/antimicrobial-stewardship-with-honey/Mentioned in this episode:EquiManagement on Audio All the articles you have come to love in EquiManagement Magazine are now available in this podcast for free. Each article is released as its own separate episode to make them quick and easy to listen to. EquiManagement always has the latest insights on equine health, veterinary practice management, and veterinarian wellness.

In this episode, Clare Ryan, DVM, PhD, DACVIM, joined us to discuss antimicrobial stewardship in equine practice. She explained why antimicrobial stewardship is important, offered suggestions for veterinarians interested in applying antimicrobial stewardship principles in their prescribing practices, and shared some resources that are available to help.This episode of Disease Du Jour is brought to you by Bimeda. GUESTS AND LINKS - EPISODE 168Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Joy Tomlinson, DVM, PhD, DACVIM (LAIM)Podcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Bimeda.Find more resources on antimicrobial stewardship at:British Equine Veterinary Association. PROTECT ME, Antibiotic UseTool KitVeterinary checklist for Antimicrobial StewardshipWHO List of Medically Important AntimicrobialsRaidal, S. (2019), Antimicrobial stewardship in equine practice. Aust Vet J, 97: 238-242. https://doi.org/10.1111/avj.12833Antimicrobial Stewardship Guidelines | Antimicrobial Stewardship GuidelinesConnect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)

In this episode, Clare Ryan, DVM, PhD, DACVIM, joined us to discuss antimicrobial stewardship in equine practice. She explained why antimicrobial stewardship is important, offered suggestions for veterinarians interested in applying antimicrobial stewardship principles in their prescribing practices, and shared some resources that are available to help.This episode of Disease Du Jour is brought to you by Bimeda. GUESTS AND LINKS - EPISODE 168Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)Guest: Joy Tomlinson, DVM, PhD, DACVIM (LAIM)Podcast Website: Disease Du JourThis episode of Disease Du Jour podcast is brought to you by Bimeda.Find more resources on antimicrobial stewardship at:British Equine Veterinary Association. PROTECT ME, Antibiotic UseTool KitVeterinary checklist for Antimicrobial StewardshipWHO List of Medically Important AntimicrobialsRaidal, S. (2019), Antimicrobial stewardship in equine practice. Aust Vet J, 97: 238-242. https://doi.org/10.1111/avj.12833Antimicrobial Stewardship Guidelines | Antimicrobial Stewardship GuidelinesConnect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)

In this episode of The SHEA Podcast, host Dr. Jonathan Ryder (University of Nebraska Medical Center) speaks with Dr. Aditi Ramakrishnan (Washington University in St. Louis) about how antimicrobial stewardship programs can play a vital role in managing and preventing resistant sexually transmitted infections. They explore the challenges and opportunities at this intersection — from the promise and controversy surrounding doxycycline post-exposure prophylaxis (DoxyPEP), to the debate over routine STI screening among populations on PrEP, and the broader stewardship considerations beyond antibiotic use.

In the final episode of this series, Susanna Esposito explores how vaccine coverage, microbiome preservation, and emerging therapeutics intersect with antimicrobial stewardship. She also discusses innovative strategies, such as bacteriophages, microbiome-targeted therapies, and AI-driven predictive analytics, to prevent infections while optimising antibiotic use in children. Timestamps: 00:00 – Introduction 00:50 – Vaccine coverage 02:20 – Gut–lung axis 03:23 – Microbiome-targeted therapies 04:37 – Bacteriophages 05:45 – AI analytics 06:30 – Final message

In the second deep dive of the series, Susanna Esposito discusses the latest guidelines for diagnosing and treating bacterial meningitis in children. She highlights balancing urgent empirical therapy with stewardship principles, appropriate use of corticosteroids, emerging resistance patterns, and how hospitals can leverage local data to optimise antibiotic prescribing. Timestamps: 00:00 – Introduction 00:53 – Tackling meningitis 02:42 – Corticosteroid use 03:37 – Access, Watch, and Reserve (AWaRe) classification 05:49 – Resistance patterns 06:51 – Point prevalence surveys

From CAR-T therapies to viral vectors, cell and gene treatments are redefining the boundaries of pharmacy practice—but with innovation comes complexity. Host Carolyn Liptak welcomes Dr. Mark Wiencek, Principal Microbiologist with the Technical Services Group at Contec, and Dr. Amanda Frick, Senior Clinical Manager of Market Intelligence at Vizient, to break down the challenges of compounding these advanced therapies.   Listen in as they discuss real-world risk assessments, biosafety considerations, and how hospital pharmacies can safely manage these groundbreaking yet high-risk treatments.   Guest speakers:  Mark Wiencek, PhD Principal Microbiologist, Technical Services Group Contec Amanda Frick, PharmD, BCPS Senior Clinical Manager, Market Intelligence Vizient   Host:  Carolyn Liptak, MBA, RPh  Pharmacy Executive Director  Vizient   Show Notes:  [01:02-01:51] Mark shares his background and experience in microbiology [01:52-04:04] Overview of the types of cell and gene therapies (CGT) currently used in clinical practice [04:05-05:14] Which CGT therapies are most applicable to pharmacy compounding and why [05:15-10:29] Things not on the NIOSH list and the risks [10:30-12:03] Evaluating whether viral vectors can penetrate intact skin and the true occupational exposure risks [12:04-13:18] If hazards are not defined by the NIOSH list, how should these CGT hazards be classified [13:19-15:03] Determining the safest environment for compounding CGT therapies [15:04-20:14] Best practices for decontamination, disinfection, and viral vector handling [20:15-20:59] Do you need a dedicated biosafety cabinet for CGT therapies [21:00-22:55] Recommended resources for further learning   Links | Resources:   Blind and colleagues (Nationwide): Click here Wang and colleagues (Stanford): Click here CONTEC HEALTHCARE WEBINAR Using Bugs as Drugs: Compounding Viral Vectors in Cell & Gene Therapy for Hospital Pharmacies, Mark Wiencek, May 13, 2025: Click here Blind, J.E., Ghosh, S., Niese, T.D., Gardner, J.C., Stack-Simone, S., Dean, A. and Washam, M., 2024. A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies. Antimicrobial Stewardship & Healthcare Epidemiology, 4(1), p.e15. Click here Deramoudt, L., Pinturaud, M., Bouquet, P., Goffard, A., Simon, N. and Odou, P., 2024. Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy. Occupational and Environmental Medicine, 81(12), pp.615-621. Click here Korte, J., Mienert, J., Hennigs, J.K. and Körbelin, J., 2021. Inactivation of adeno-associated viral vectors by oxidant-based disinfectants. Human Gene Therapy, 32(13-14), pp.771-781. Click here (abstract only; full article available for purchase) Martino, J.G., McConnell, K., Greathouse, L., Rosario, B.D. and Jaskowiak, J.M., 2024. Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center. Journal of Oncology Pharmacy Practice, 30(8), pp.1442-1449. Click here Penzien, C., 2023. Safe handling of BioSafety drugs and live virus vaccines. Pharm Purch Prod, 20(4), p.12. Click here Petrich, J., Marchese, D., Jenkins, C., Storey, M. and Blind, J., 2020. Gene replacement therapy: a primer for the health-system pharmacist. Journal of Pharmacy Practice, 33(6), pp.846-855. Click here Wang, A., Ngo, Z., Yu, S.J. and MacDonald, E.A., 2025. Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting. American Journal of Health-System Pharmacy, p.zxaf026. Click here   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

Susanna Esposito joins Saranya Ravindran to explore how clinicians can distinguish viral from bacterial respiratory infections in children. From bronchiolitis management to targeted testing, stewardship strategies, and the role of vitamin D and point-of-care diagnostics, this episode unpacks evidence-based approaches to reduce unnecessary antibiotic use.  Timestamps:  00:00 – Introduction  02:00 – Respiratory infections  03:30 – Targeted testing  04:12 – Antibiotics in bronchiolitis  05:52 – Stewardship initiatives  07:12 – Vitamin D in prevention  08:21 – Viral point-of-care diagnostics 

In this rapid-fire episode, Susanna Esposito answers key questions about antimicrobial stewardship in children, from identifying viral versus bacterial infections, to emerging diagnostics and best practices for rational antibiotic use. Perfect for listeners short on time. 

In our first episode released in both English and Spanish, Drs. Laila Woc-Colburn and Nicholás Ignacio Valdebenito Farías join Dr. José Pablo Díaz Madriz to discuss the role of the pharmacist in antimicrobial stewardship in Latin America. They discuss the need for growth of antimicrobial stewardship programs across Latin America, how pharmacists can expand their roles to support multidisciplinary antimicrobial stewardship teams, and much more!   Listen to Breakpoints on iTunes, Overcast, Spotify, Listen Notes, Player FM, Pocket Casts, TuneIn, Blubrry, RadioPublic, or by using our RSS feed: https://sidp.pinecast.co/. Visit our website! https://breakpoints-sidp.org/ References: Ciapponi A, Bardach A, Sandoval MM, Palermo MC, Navarro E, Espinal C, Quirós R. Systematic review and meta-analysis of deaths attributable to antimicrobial resistance, Latin America. Emerg Infect Dis. 2023 Nov;29(11):2335-44. doi:10.3201/eid2911.230753. PMID:37877573; PMCID:PMC10617342. Antimicrobial Resistance Collaborators. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. Lancet Reg Health Am. 2023 Aug 8;25:100561. doi:10.1016/j.lana.2023.100561. Erratum in: Lancet Reg Health Am. 2023 Nov 10;28:100632. doi:10.1016/j.lana.2023.100632. PMID:37727594; PMCID:PMC10505822. Fabre V, Secaira C, Cosgrove SE, Lessa FC, Patel TS, Alvarez AA, Anchiraico LM, Del Carmen Bangher M, Barberis MF, Burokas MS, Castañeda X, Colque AM, De Ascencao G, Esquivel C, Ezcurra C, Falleroni LA, Frassone N, Garzón MI, Gomez C, Gonzalez JA, Hernandez D, Laplume D, Lemir CG, Maldonado Briones H, Melgar M, Mesplet F, Martinez G, Pertuz CM, Moreno C, Nemirovsky C, Nuccetelli Y, Palacio B, Sandoval N, Vergara H, Videla H, Villamandos S, Villareal O, Viteri A, Quiros R. Deep dive into gaps and barriers to implementation of antimicrobial stewardship programs in hospitals in Latin America. Clin Infect Dis. 2023 Jul 5;77(Suppl 1):S53-S61. doi:10.1093/cid/ciad184. PMID:37406044; PMCID:PMC10321692. Charani E, Smith I, Skodvin B, Perozziello A, Lucet JC, Lescure FX, Birgand G, Poda A, Ahmad R, Singh S, Holmes AH. Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries: a qualitative study. PLoS One. 2019 Jan 16;14(1):e0209847. doi:10.1371/journal.pone.0209847. PMID:30650099; PMCID:PMC6335060. Bavestrello L, Cabello Á, Casanova D. Impact of regulatory measures on antibiotic sales in Chile. Rev Med Chil. 2002 Nov;130(11):1265-72. doi:10.4067/S0034-98872002001100009. ISSN 0034-9887. Díaz-Madriz JP, et al. Impact of a pharmacist-driven antimicrobial stewardship program in a private hospital in Costa Rica. Rev Panam Salud Publica. 2020;44:e57. doi:10.26633/RPSP.2020.57. Díaz-Madriz JP, et al. Impact of a pharmacist-driven antimicrobial stewardship program on the prescription of antibiotics by intensive care physicians in a Latin American hospital: a retrospective study. J Am Coll Clin Pharm. 2022;5(11):1148-55. doi:10.1002/jac5.1708. Domínguez I, et al. Evaluación del consumo de antimicrobianos en 15 hospitales chilenos: resultados de un trabajo colaborativo, 2013. Rev Chil Infectol. 2016 Jun;33(3):307-12. doi:10.4067/S0716-10182016000300010. ISSN 0716-1018. Ministerio de Salud de Chile. Norma general técnica N°210 para la racionalización del uso de antimicrobianos en la atención clínica. Resolución Exenta N°1146, 2020. Disponible en: https://diprece.minsal.cl/wp-content/uploads/2021/01/RES.-EXENTA-N%C2%B01146-Aprueba-Norma-Gral.-Te%CC%81cnica-N%C2%B00210-para-la-racionalizacio%CC%81n-del-uso-de-antimicrobianos-en-la-Atencio%CC%81n-Cli%CC%81nica_v2.pdf

Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: Who should be tested for infectious diarrheaTypes of gastrointestinal syndromic panelsTypes of syndromic panels for joint infectionsReal-world applications for joint syndromic panelsPresenters: Trevor Van Schooneveld, MDProfessor, Division of Infectious DiseasesMedical Director, Antimicrobial Stewardship ProgramDepartment of Internal MedicineUniversity of Nebraska Medical CenterOmaha, NebraskaLink to full program: https://bit.ly/4mHOTtWGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:Types of upper and lower respiratory infection panelsConsiderations for when to use respiratory syndromic testingHow to use syndromic testing to guide both therapy escalation and de-escalationHow syndromic testing fits in with traditional testing methods, such as culture, antimicrobial susceptibility testing, Gram stain, and BAL cell count Presenter:Michael Satlin, MD, MS, FIDSAAssociate Professor of Medicine and Pathology and Laboratory MedicineWeill Cornell MedicineNew York, New YorkLink to full program: https://bit.ly/3UAB1oUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:The importance of good blood culture practices and finding the balance between overuse and underuseBlood culture improvement programsThe utility of rapid diagnostic testsResistance markers for earlier targeted therapyPresenters:Emily Heil, PharmD, MS, BCIDP, AAHIVPProfessorDepartment of Practice, Sciences, and Health Outcomes ResearchUniversity of Maryland School of PharmacyBaltimore, MarylandLink to full program: https://bit.ly/45Ajz92Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison, Dr. April Dyer, talks to us about an article in Antimicrobial Stewardship & Healthcare Epidemiology entitled "Implementation and performance of a nurse administered modified PEN-FAST clinical decision rule in the electronic health record." The article can be found here: https://pubmed.ncbi.nlm.nih.gov/40697885/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

Want to elevate your infection prevention career? Dive into this inspiring episode with Gail Fraine and Dr. Mayar Al Mohajer as they explore the value, purpose, and impact of the Advanced Leadership Certification in Infection Prevention (AL-CIP). Learn how this credential empowers professionals to lead change, drive outcomes, and shape healthcare policy. Get tips for submission success and hear firsthand experiences from these certified leaders! Hosted by: Kelly Holmes, MS, CIC, FAPIC and Lerenza L. Howard, MHA, CIC, LSSGB About our Guests: Gail Fraine, CIC, LTC-CIP, AL-CIP Gail Fraine is the System Director of Infection Prevention at Ascension Saint Thomas in Nashville, TN, with over 30 years of experience reducing healthcare-associated infections through evidence-based practices and high-reliability principles. A long-standing APIC member, she has held national leadership roles including Board Director and Annual Conference Chair. Gail currently serves as President-Elect of the Certification Board of Infection Control and Epidemiology (CBIC) and contributed to developing both the long-term care and Advanced Leadership certifications. She holds nursing degrees from Arkansas State, Belmont, and Vanderbilt, and is certified in CIC, LTC-CIP, and AL-CIP. Mayar Al Mohajer, FIDSA, FSHEA, FAPIC, FACHE, AL-CIP Dr. Al Mohajer serves as Professor of Medicine in the Section of Infectious Diseases at Baylor College of Medicine in Houston, Texas, where he also directs the Infection Prevention, Antimicrobial Stewardship, Quality Improvement, and Leadership Track. He is the Chief of the Infectious Disease Section at Baylor St. Luke's Medical Center and the Medical Director of Infection Prevention, Occupational Health, Diagnostic Stewardship, and Antibiotic Stewardship for CommonSpirit Health's South Region and Baylor St. Luke's Medical Center. In addition to his clinical and academic roles, Dr. Al Mohajer sits on the CBIC Board and co-chairs the National Infection Prevention Council for CommonSpirit Health. He holds multiple fellowships and certifications recognizing his expertise and leadership, including FIDSA, FSHEA, FAPIC, FACHE, and AL-CIP.

Join DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard as she reviews the recent article published in Antimicrobial Stewardship & Healthcare Epidemiology titled: “(Re)Moving the Needle: A Retrospective, Quasi-Experimental Assessment of the Impact of a Treatment Guideline on Oral Antibiotic Prescribing for Orthopedic Infections." She discusses how this study highlights the real-world impact of guideline implementation on shifting antibiotic prescribing practices for bone and joint infections. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/40160226/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

A common yet often misunderstood infection is popping up in different corners of our community. Mycoplasma pneumonia, otherwise referred to as walking pneumonia, can present in a way that's subtle and sneaky, with a plethora of symptoms. This ‘silent' infection can fly under the radar leaving both patients and providers puzzled, but we want to make sure our listeners feel prepared to tackle this diagnosis.  How do we ensure it doesn't slip through the cracks? How do we identify it in our patients? We'll discuss all that and more in this episode.   Joining us for this exciting discussion are Lilliam Ambroggio, PhD, and Michael Bozzella, DO. Dr. Ambroggio is the Director of Research in the sections of Emergency Medicine and Hospital Medicine at Children's Hospital Colorado. She is also an Associate Professor of Pediatrics at the University of Colorado School of Medicine. Dr. Bozzella is the Associate Medical Director of Antimicrobial Stewardship and specializes in infectious disease. He is also an Assistant Professor of Pediatrics. Some highlights from this episode include:  Understanding where it colonizes and how it spreads  How to identify this disease properly, as the presentation can look like many different illnesses  How the epidemiology informs what primary care providers should know about this diagnosis  Knowing when to test For more information on Children's Colorado, visit: childrenscolorado.org. 

Send us a textDr. Jennifer Granick takes us deep into her groundbreaking research on antibiotic prescribing patterns in companion animal practice, revealing both challenges and opportunities for improvement.This conversation unveils the complex reality of veterinary prescribing. Perhaps most surprising is the finding that preventive antibiotic treatments typically last the same duration (10 days) as those targeting confirmed infections—a practice without scientific justification.What makes this discussion particularly valuable is Dr. Granick's practical approach to creating change. Rather than overwhelming practitioners with an insurmountable challenge, she advocates starting small: "Pick one common condition, check prescribing guidelines, and make one small change." This accessible strategy empowers veterinarians to contribute meaningfully to antimicrobial stewardship without complete practice overhauls. Meanwhile, pet owners gain crucial perspective on when antibiotics truly help versus when they might cause harm.As Dr. Granick's team explores innovative methods using electronic health records and AI to gather prescribing data while maintaining privacy, the future of veterinary antimicrobial stewardship looks promising. Her parting wisdom serves as both warning and hope: antibiotics are indeed life-saving, but only if they continue to work. Join us for this essential conversation at the intersection of companion animal medicine, public health, and our shared responsibility to preserve these precious medications for generations to come.Open access JAVMA article: https://doi.org/10.2460/javma.24.11.0716INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

In this episode, listen in as our expert panel digs into identifying and treating acute bronchitis and community-acquired pneumonia. They'll discuss when antibiotics are appropriate, which antibiotics to use, and other management tips.You'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLM, Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, GreenvilleAndrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - PhoenixCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Chart: Managing Community-Acquired Pneumonia and Aspiration Pneumonia in AdultsFAQ: Antibiotic Therapy: When Are Shorter Courses Better?Chart: Managing Cough and Cold SymptomsSend us a textCheck out our NEW podcasts. Rumor vs TruthYour trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.Clinical CapsulesTRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.If you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

You can text us here with any comments, questions, or thoughts!In our latest episode, Kemi sit down with Dr. Sharon Onguti, an infectious diseases specialist at Vanderbilt University Medical Center, where she has served since 2022. Board-certified in Internal Medicine and Infectious Diseases, she completed her fellowship at UT Health San Antonio and a sub-fellowship in Antimicrobial Stewardship at Stanford University. Dr. Onguti holds an MPH in Epidemiology and Biostatistics from Johns Hopkins Bloomberg School of Public Health and is a board member of the Society of Bedside Medicine, she is dedicated to medical education and serves as Associate Program Director of the Infectious Diseases Fellowship Program. She is also is an alumnus of our Get That Grant® coaching program! Join the conversation as Dr. Onguti shares her remarkable journey in medicine, highlighting her innovative use of AI in healthcare. Highlights: Discover how she navigates multiple roles and responsibilities while finding clarity and focus through coaching.  The importance of aligning your career with personal values and interests.  Why regular reflection and inventory of your activities help ensure alignment with long-term goals. Insights on cultivating a high-functioning support network and redefining mentorship to propel your career forward. Loved this convo? Please go find Dr. Onguti on LinkedIn and Twitter/X show her some love!  If you'd like to learn more foundational career navigation concepts for women of color in academic medicine and public health, sign up for our KD Coaching Foundations Series: www.kemidoll.com/foundations. And if you're also a high-achieving WOC facing these challenges and seeking to navigate your path more effectively, Get That Grant is here to support you! Join the waitlist for our April 2025 Get That Grant cohort! Enrollment for the April cohort is exclusive to our waitlist, so sign up now to take the first step toward turning your aspirations into reality. Applications will be sent directly to the waitlist on Monday, February 17.  Sign up for the waitlist now at  www.kemidoll.com/gtgwaitlist REMINDER: Your Unapologetic Career Podcast now releases episode every other week! Can't wait that long? Be sure you are signed up for our newsletter (above) where there are NEW issues every month! 

In this episode of the SHEA Podcast, moderator Dr. Sheetal Kandiah, Director of the Antimicrobial Stewardship Program at Emory University Hospital, explores the role of Artificial Intelligence (AI) in antimicrobial stewardship with Dr. Richard Medford, ECU Health's Chief Medical Informatics and Digital Health Officer (CMIDHO). Dr. Medford discusses how AI-driven tools are transforming antibiotic stewardship, improving prescribing accuracy, patient outcomes, and resistance management. The conversation highlights current applications, including predictive analytics and clinical decision support, as well as the impact of big data on stewardship programs. The episode also examines real-world successes where AI has optimized antibiotic use and enhanced patient care, along with key challenges in AI adoption, such as data reliability, ethical concerns, and provider trust. Looking ahead, Dr. Medford shares insights on future AI advancements that could further shape antimicrobial stewardship and healthcare innovation.

Show notes at pharmacyjoe.com/episode999. In this episode, I'll discuss whether delayed broad-spectrum antibiotics have an impact on clinical outcomes. The post 999: Is This Study a Breakthrough for Antimicrobial Stewardship? appeared first on Pharmacy Joe.

On this episode of The ICHE Podcast, we dive into research priorities in healthcare-associated infections (HAIs) and antimicrobial stewardship (AS) with experts Robin Jump, Jennie Kwon, Daniel Livorsi, Lona Mody, and Eli Perencevich. The discussion explores the importance of publishing research agendas to stimulate focused research, guide researchers in prioritizing critical topics, and inform funding decisions. By addressing these goals, the panel aims to align research efforts with pressing clinical challenges, foster innovation, and bridge gaps between research and implementation. The guests also discuss the structured methodologies used to draft these research agendas, detailing how key priorities were identified and refined to address the most urgent needs in the field. The panel reviews three recently published agendas in ICHE: A Call to Action: The SHEA Research Agenda to Combat Healthcare-Associated Infections, Research Agenda for Transmission Prevention within the Veterans Health Administration, 2024–2028, and Research Agenda for Antibiotic Stewardship within the Veterans Health Administration, 2024–2028. Key topics include addressing antimicrobial resistance, improving diagnostic tools, and tackling HAIs in vulnerable populations. The conversation further examines the applicability of findings from VA-specific agendas to non-VA healthcare settings, concluding that many insights are broadly relevant. Listeners will gain a clearer understanding of the research landscape and actionable ways to contribute to advancements in patient safety and healthcare quality. For further details, explore the full articles discussed in this episode at Cambridge.org/ICHE.

In this episode of The SHEA Podcast, host Dr. Leila Hojat is joined by Dr. Pretti Jaggi and Dr. Emily Spivak to explore the growing intersection of antimicrobial stewardship and sustainability in healthcare. The discussion highlights how stewardship programs can reduce the environmental impact of antibiotic production and use, particularly by addressing pharmaceutical waste. The guests share insights into how optimizing antibiotic use promotes more efficient resource utilization, contributing to a broader sustainability agenda. They emphasize the alignment of combating antibiotic resistance with the goals of sustainable healthcare, underscoring the long-term benefits of this synergy. Interdisciplinary approaches, blending antimicrobial stewardship with environmental science and public health, are highlighted as promising solutions to infectious disease management. The conversation also delves into future innovations in stewardship practices, including advancements in technology and collaboration, which are expected to drive significant progress in sustainable healthcare.

In this episode Dhineli Perera speaks to John Turnidge, who leads the national surveillance program for Antimicrobial Use and Resistance in Australia. They discuss the significant impact of the pandemic on reducing antibiotic use in the community, and how this benefit can be sustained and improved on. Read the full article by John and his co-authors, Carolyn Hullick and Kim Stewart, in Australian Prescriber.

In this special episode for World Antimicrobial Resistance Awareness Week, we welcome Dr. Grace Barnes, a specialty registrar in Infectious Diseases and Microbiology, for an insightful discussion about her journey in medicine and her work in microbiology. Grace shares her path from studying medicine at Oxford University to her current role, including her formative experiences during medical electives in Australia and Hong Kong that sparked her interest in global health. She offers a fascinating glimpse into her daily work as a microbiologist, explaining how she bridges the gap between laboratory science and clinical care while collaborating with biomedical scientists, pharmacists, and other healthcare professionals to manage complex infections. The conversation explores the crucial role of multidisciplinary teamwork in treating antibiotic-resistant infections, with Grace highlighting specific examples of how collaboration between microbiologists and pharmacists leads to better patient outcomes. This episode provides valuable insights into the specialised world of clinical microbiology and infectious diseases, while highlighting the critical importance of collaborative healthcare in addressing modern medical challenges. HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

In this World Antimicrobial Resistance Awareness Week episode, we meet Bee Yean Ng, the lead antimicrobial stewardship pharmacist at Oxford University Hospitals NHS Trust. Starting her journey in Malaysia and completing her pharmacy degree through a partnership with the University of Strathclyde, Bee shares her transition from community pharmacy training to hospital practice. Despite initial challenges in making this sector switch, her positive mindset and flexibility to relocate helped her seize new opportunities. During her foundational years at Buckinghamshire Healthcare NHS Trust, Bee worked under the mentorship of Claire Brandish and Kate Russell-Hobbs, who helped shape her clinical development. Bee's career took an international turn when she became involved with the Commonwealth Partnership for Antimicrobial Stewardship grant, working between the UK and Uganda. This experience, combined with the Chief Pharmaceutical Officer's Global Health Fellowship, sparked her passion for global health and led to her first publication. Now at Oxford, she leads a partnership with Kilifi County Referral Hospital in Kenya, demonstrating her growth from team member to project leader. HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

In this World Antimicrobial Resistance Awareness Week episode, Neha Voralia shares her journey from community pharmacy to becoming an advanced anti-infectives pharmacist.  Starting at Northampton General Hospital, she discovered her passion for antimicrobial stewardship through working with complex diabetic foot infections and surgical patients. Neha discusses her transition to paediatric antimicrobial stewardship at Great Ormond Street Hospital, highlighting the unique challenges of managing resistant infections in children, from dosing complexities to medication adherence. Now working at Buckinghamshire NHS Trust, she reflects on the evolving nature of antimicrobial pharmacy and her aspirations in infectious diseases. KEY TAKEAWAYS: Antimicrobial stewardship requires extensive knowledge of bacteria, resistance patterns, and complex patient factors. Paediatric antimicrobial management presents unique challenges, from dose calculations to medication adherence strategies. The role extends beyond clinical work to include guideline development, infection prevention, and regional collaboration. Tertiary centers manage particularly complex cases where standard guidelines may not apply. Professional development opportunities in antimicrobial stewardship include research, conference presentations, and global health initiatives. HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

In this special episode of Pharmacist Diaries, recorded live during World Antimicrobial Resistance Awareness Week, I welcome back Claire Brandish, a distinguished leader in antimicrobial stewardship and global health. Claire Brandish currently works as the Lead Anti-Infectives pharmacist at Buckinghamshire Healthcare NHS Trust and Senior Antimicrobial Resistance Technical Advisor for the Commonwealth Pharmacist Association. In her role, she supports the Fleming funded Commonwealth Partnerships for Antimicrobial Stewardship Scheme (CwPAMS). As a Chief Pharmaceutical Officer's Global Health Fellow, Claire has successfully delivered three CwPAMS projects between the NHS and health-partners in the UK and Uganda. Named a "Woman to Watch" in 2021 by the Pharmaceutical Journal, Claire works as an independent prescriber and actively participates in regular antimicrobial stewardship ward rounds as part of the multidisciplinary team. Key Takeaways - Global health partnerships offer valuable opportunities for professional growth and knowledge exchange - Success in healthcare leadership requires continuous learning, mentorship, and willingness to step outside comfort zones - Effective antimicrobial stewardship requires collaboration across multiple healthcare sectors and disciplines - Personal development and career progression often involve overcoming challenges and maintaining resilience HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

In this World Antimicrobial Resistance Awareness Week (WAAW) episode, Rachel Berry shares her journey from hospital pharmacist to antimicrobial stewardship specialist. Her passion deepened when her young son was diagnosed with leukemia, highlighting the critical importance of effective antibiotics in modern medicine. Now working at the UK Health Security Agency (UKHSA) as a Chief Pharmaceutical Officer's Fellow, Rachel combines her clinical expertise with national policy work. The conversation covers the evolution of pharmacy practice, the value of independent prescribing qualifications, and the urgent need to preserve antimicrobial effectiveness for future generations. 5 key takeaway messages: Antimicrobial resistance is an immediate threat affecting patient outcomes today, not a future concern. Pharmacy careers can evolve from ward-based roles to national policy influence through continuous development. Working with chronic conditions provides invaluable experience in managing complex infections and building patient relationships. National leadership programs like the Chief Pharmaceutical Officer's Fellowship enable pharmacists to shape healthcare policy. Career advancement can be strategically timed with different life stages without compromising family commitments. HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

In this powerful World Antimicrobial Resistance Awareness Week (WAAW) special episode, we hear from Vanessa Carter, a remarkable Antimicrobial Resistance (AMR) survivor turned global health advocate. After a devastating car accident in 2004 led to multiple facial reconstruction surgeries, Vanessa developed a drug-resistant MRSA infection that changed her life's trajectory. Her journey from patient to Chair of the WHO Task Force of AMR Survivors highlights the critical importance of patient education and antimicrobial stewardship. Vanessa shares crucial insights about the gaps in patient communication, the need for better infection prevention education, and the importance of tracking antibiotic usage. Key Takeaway Messages: For Healthcare Professionals: Simple, clear communication about infection risks can save lives Consider patient literacy levels when explaining complex concepts Integrate infection prevention education throughout the patient journey Collaborate across specialties for better patient outcomes For Patients: Ask questions about infection prevention and control Keep records of antibiotic treatments when possible Watch for signs of recurring infections Don't hesitate to seek help if infections don't improve For Policy Makers: Include patient voices in healthcare system design Invest in better diagnostic tools Develop integrated antibiotic tracking systems Support early education initiatives about AMR HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

Frances Garraghan, Consultant Pharmacist at Manchester University NHS Foundation Trust and AMR Technical Lead for the Commonwealth Pharmacist Association, shares her inspiring journey from NHS pharmacist to global Antimicrobial Resistance (AMR) leader. In this wonderful conversation, Fran reveals how she transitioned from surgery to antimicrobial stewardship, driven by personal experiences that shaped her career path. She discusses the unique challenges of tackling high resistance rates in Manchester's diverse patient population and how this led to innovative training programs incorporating behavioural science principles. The episode delves deep into Fran's transformative work with the Commonwealth Pharmacists Association (CPA), particularly her experiences in Uganda where she helped train over 200 healthcare workers. She shares candid insights about culture shock, adaptation, and the profound impact of global health work on her NHS practice. You will gain valuable insights into the development of sustainable healthcare partnerships, the importance of behavioural change in antimicrobial stewardship, and the critical role of pharmacists in global health initiatives.  Fran's story illuminates how local NHS experience can translate into meaningful global impact, while emphasising the importance of cultural competency and adaptability in healthcare leadership. HAVE YOU EVER THOUGHT ABOUT LIFE OUTSIDE THE TRADITIONAL 9-5? Are you a pharmacist dreaming of: - Working on your own terms? - Achieving location independence? - Building financial freedom? I've been there. That's why I'm sharing my journey from traditional 9-5 pharmacist to creating a life of freedom and fulfillment. In this weekly newsletter, I'll be opening up about my transition to unconventional pharmacy, practical tips for working on your own terms, strategies for financial independence, and our family's adventures in homeschooling and world travel. Ready to reimagine what's possible in your pharmacy career and life? Sign up

Topics covered: - Defining antimicrobial stewardship- New randomized clinical trial looking at how stewardship prompts improve antibiotic selection for pneumonia- Resources and how CommonSpirit Health is taking action and addressing this important topicGuest expert: Dr. Renuga Vivekanandan, Infectious Disease Expert, Division VP and CMO Physician Enterprise - Midwest, Professor, Associate Dean for Clinical Affairs, Creighton University School of Medicine

Nurse Lead CNM3 in Antimicrobial Stewardship in St James's Hospital Carolyn O' Reilly joins us today to speak about her pilot role. Please leave us any feedback or send episode suggestions to icueducationteam@stjames.ie Enjoy the episode! Of note: This episode was recorded in January 2024

We all know what antimicrobial stewardship (AMS) is, but implementation in the community pharmacy space is something that is still developing. This podcast episode will empower listeners to recognize that there are small things that they can do to improve AMS in the community setting. The episode will also discuss how the Centers of Disease Control's core elements of outpatient AMS apply to practitioners in a community pharmacy setting. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Carbapenemase producers are a nightmare for clinicians. Not only are they resistant to carbapenems, a last resort β-lactam antibiotic, they are notorious for developing multidrug and pandrug resistances resulting in limited to no treatment options.  In this episode of Communicable, hosts Angela Huttner and Thomas Tängdén sit down with Dr. David Paterson (National University of Singapore) and Dr. Souha Kanj (American University of Beirut Medical Center, Lebanon), two ID physicians from regions where carbapenem-resistant Enterobacteriaceae or CRE, and carbapenem-resistant Acinetobacter are widespread.  The episode begins with the history and emergence of CRE and reviews current epidemiology, diagnosis (including the Ambler classification of β-lactamases) and treatment options. Lessons and insights from personal experiences are shared to reflect the current clinical challenges caused by carbapenem-resistant bacteria and the importance of infection prevention and control measures to mitigate further spread. This episode was edited by Kathryn Hostettler and peer-reviewed by Dr. Filippo Medioli of Policlinico di Modena, Italy. For more related content on the WHO Priority Pathogens List and new antibiotics in the pipeline, check out our previous episodes, Communicable E3 and E10 (see Literature).Literature Communicable E3 - The New WHO Priority Pathogens List: which bugs to target first? June 2024. https://communicable.transistor.fm/episodes/communicable-e3-the-new-who-priority-pathogens-list-which-bacteria-to-target-first  Communicable E10 - Pipeline update: new antibiotics & other antimicrobials that you might actually use. Sep 2024. https://communicable.transistor.fm/episodes/communicable-e10-pipeline-update-new-antibiotics-other-antimicrobials-that-you-might-actually-use  Wagenlehner FM, et al. Cefepime-Taniborbactam in Complicated Urinary Tract Infection. N Engl J Med 2024 Feb. doi: 10.1056/NEJMoa2304748 Cohn J, et al. Accelerating antibiotic access and stewardship: a new model to safeguard public health. Lancet Infect Dis 2024 Sep. doi:  10.1016/S1473-3099(24)00070-7 Timsit JF, et al. When should I start broad-spectrum antibiotics? Intensive Care Med 2024 Sep. doi: 10.1007/s00134-024-07654-7  Paterson DL. Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials. Expert Opin Investig Drugs 2024 Apr. doi: 10.1080/13543784.2024.2326028 

On the verge of a post-antibiotic reality, there is an urgent clinical need for new antibiotics. Luckily, new candidates are in the pipeline and older agents are getting a second breath of life through combination therapy.  In this episode of Communicable, host Erin McCreary invites Dr. Markus Zeitlinger of the University of Vienna (Austria) and scientific expert for the European Medicines Agency (EMA) and Dr. Michael Dudley, president and CEO of Qpex Biopharma, to discuss antimicrobials in the clinical development pipeline.  Together they unpack how the WHO curate the priority list of pathogens and how companies adapt such lists into their antimicrobial development business plans. They also discuss the unique challenges and complexities of developing antibiotics, from return on investments and defining the ‘novelty' of an agent to the conundrum of balancing post-market approval and antimicrobial stewardship. Beta-lactamase inhibitors and oral carbapenems in the pipeline targeting ‘the big three' (Enterobacterales, Pseudomonas and Acinetobacter) are the primary focus. This episode was edited by Kathryn Hostettler and peer-reviewed by Dr. Benjamin Berinson of the Medical Centre Hamburg-Eppendorf (UKE), Germany. For more information on the WHO Priority Pathogens List and its 2024 update, check out our previous episode, Communicable E3 (see Literature).  Literature  Communicable E3 - The New WHO Priority Pathogens List: which bugs to target first? 17 June 2024. https://communicable.transistor.fm/episodes/communicable-e3-the-new-who-priority-pathogens-list-which-bacteria-to-target-first  WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 17 May 2024. https://www.who.int/publications/i/item/9789240093461  C. Le Terrier et al, NDM-9 resistance to taniborbactam. Lancet Infect Dis 23, 401-402 (2023). doi 10.1016/S1473-3099(23)00069-5      P. B. Eckburg et al, Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection. N Engl J Med 386, 1327-1338 (2022). doi: 10.1056/NEJMoa2105462  A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (PIVOT-PO). https://clinicaltrials.gov/study/NCT06059846 Meiji Seika Pharma Initiated the Global Phase III Clinical Trials of OP0595, a Novel beta-Lactamase Inhibitor for Combatting Antimicrobial Resistance (AMR). Tokyo: Meiji Seika Pharma Ltd; 26 April 2023. https://www.meiji.com/global/news/2023/pdf/230426_01.pdf

Only known to us since 2008, Candida auris is an emerging fungal pathogen spreading quickly around the world; alarmingly, it is most commonly found in healthcare settings. C. auris sets itself apart from other Candida species with its unique tolerance to high saline and temperature environments and propensity to develop antifungal resistances that promote its survival in hospitals and healthcare facilities. Hosts Emily McDonald and Navaneeth Narayanan are joined by fungal experts Dr. Jeffrey Rybak (St. Jude, Memphis TN) and Dr. Graham Snyder (UPMC, Pittsburgh PA) on their quest to better understand C. auris infections, the clinical challenges and knowledge gaps in C. auris research and discuss measures for prevention and containment on the levels of both the patient and the institution. The recent emergence of C. auris as a multidrug-resistant nosocomial pathogen and its global prevalence has raised more questions than answers. Why now? Why healthcare facilities? Does climate change play a role? Are humans to blame? Tune in to find out what the experts have to say on these questions, and stay to learn about the current therapies available, what is in the antifungal pipeline and how to approach treatment from a stewardship standpoint.This episode was produced by Angela Huttner, edited by Kathryn Hostettler and peer-reviewed by Dr. Claudio Neidhöfer of University Hospital Bonn, Germany.LiteratureSatoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009 Jan;53(1):41-4. doi: 10.1111/j.1348-0421.2008.00083.xLee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011 Sep;49(9):3139-42. doi: 10.1128/JCM.00319-11Pfaller MA, Diekema DJ, Turnidge JD, et al. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016. OFID. 2019 March;6(S1): S79–S94. doi: 10.1093/ofid/ofy358Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2017 Jan 15;64(2):134-140. doi: 10.1093/cid/ciw691.Clancy CJ, Nguyen MH. Emergence of Candida auris: An International Call to Arms. Clin Infect Dis. 2017 Jan 15;64(2):141-143. doi: 10.1093/cid/ciw696Rybak JM, Cuomo CA, Rogers PD. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida auris. Curr Opin Microbiol. 2022 Dec;70:102208. doi: 10.1016/j.mib.2022.102208 

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Eric Moore from Norbrook Laboratories, and Dr. John Sharpe, a practicing veterinarian in Kansas and a 2023 graduate of Kansas State University.  This podcast is sponsored by Norbrook. Having the right antibiotics is critical to successfully treating seasonal diseases. Norbrook offers a variety of effective and value driven solutions such as Noromycin 300 LA, Norfenicol Injectable Solution, Tulieve Injectable Solution, Enroflox 100 Injectable Solution, and Cefenil RTU. To learn more, contact your Norbrook sales representative, your animal health distributor, or visit the Norbrook website.  Sharpe discusses the seasonal variation of disease patterns he sees in his bovine practice and how these patterns influence antibiotic use as well as the producer's bottom line. He also shares his experiences with the implementation of GFI #263 which transitioned the remaining medically important over-the-counter antimicrobials to prescription status with veterinary oversight. We also discuss how he, as a veterinarian, walks through his decision-making processes for selecting an antimicrobial to treat an animal, herd or in protocol development. Moore provides some background on the frustration producers face when they experience treatment failure, how prevention is the most important part of a stewardship program, and what antibiotics do not do so that producers can understand how to use them properly and promote animal health.  Listen to the previous podcast with Dr. Eric Moore on implementation of GFI #263 here. Make sure to visit the Norbrook booth at the AABP tradeshow at the upcoming 57th AABP Annual Conference in Columbus, Ohio, September 12-14, 2024. 

Dr. Kerl is pleased to welcome Dr. Anne Kimmerlein to the podcast. Listen in as Dr. Kimmerlein, a veterinary epidemiologist with VCA Medical Operations, shares her journey in veterinary medicine and her role at VCA. In their conversation, they discuss the importance of the interconnectedness between people and their pets and the growing field of veterinary epidemiology. During the COVID-19 pandemic, Dr. Kimmerlein played a crucial role in providing guidance and protocols for hospitals and ensuring the safety of patients, clients, and associates. She also conducted a study on pets in households of people with COVID-19, finding that pets can get infected with the virus. Additionally, Dr. Kimmerlein discusses her work with the VCA clinical studies team, her involvement in antimicrobial stewardship, and her passion for shelter medicine.Visit our website: vcavoice.comAll episodes produced by dādy creative

   Join us on War Docs as we welcome Army Physician MAJ Mary Ford, an infectious disease specialist and lead author of the acclaimed Military Medicine Journal's article of the year: Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa Isolated From Combat Casualties https://pubmed.ncbi.nlm.nih.gov/34196358/    Listen in as MAJ Ford shares the impactful findings of her team's research on Pseudomonas aeruginosa in combat casualties, a topic of paramount importance to military health. Her personal journey into the infectious disease field, spurred by early curiosities and familial influences, and the progression of her military career make for a captivating story of dedication and passion.       In this engaging conversation, we also tackle the critical subject of infection prevention and antimicrobial stewardship in the face of combat trauma. Hear about the vital role of simple measures, like hand hygiene, in combating infections, especially those caused by the antibiotic-resistant Pseudomonas aeruginosa. Discover how MAJ Ford's team utilized the Trauma Infectious Disease Outcomes Study to uncover that approximately 6% of combat trauma patients developed Pseudomonas infections. The implications of these findings are vast, offering significant advancements for clinical outcomes and infection control in military medical settings. Tune in for a deep understanding of how such research continues to shape practices and policies within the Department of Defense.   Chapters: (00:02) Infectious Disease in the Military (07:12) Combat Trauma Infections and Pseudomonas   Chapter Summaries: (00:02) Infectious Disease in the Military  MAJ Mary Ford's research on Pseudomonas aeruginosa in combat casualties and its impact on military health, her personal journey into infectious disease, and the enduring need for ongoing research in the Department of Defense.   (07:12) Combat Trauma Infections and Pseudomonas   Infection prevention and antimicrobial stewardship are crucial in controlling Pseudomonas infections in combat trauma patients.   Take Home Messages: In the context of military medicine, the issue of infections following combat trauma is a significant concern, with Pseudomonas aeruginosa identified as a noteworthy pathogen due to its prevalence in prolonged hospital stays and its intrinsic antibiotic resistance mechanisms. Infection prevention and antimicrobial stewardship are critical components in the management of combat trauma infections. Basic practices such as hand hygiene play a pivotal role in controlling the spread of infections and can have substantial impacts on patient outcomes. Research conducted through the Trauma Infectious Disease Outcomes Study (T-DOS) has revealed that about 6% of combat trauma patients develop Pseudomonas infections, which underscores the importance of understanding and addressing these infections to improve clinical practices and infection control protocols. Combat trauma patients with Pseudomonas infections often experience lengthy hospital stays and intensive care unit admissions, highlighting the need for robust infection prevention strategies in military healthcare settings to reduce the burden of these nosocomial infections. The fight against infections like Pseudomonas aeruginosa in military medicine is an ongoing challenge that requires continuous research and evidence-based practices to ensure the health and readiness of military personnel. Basic infection control measures remain foundational in mitigating infectious threats.   Episode Keywords:  Military Medicine, Infectious Disease, Pseudomonas aeruginosa, Combat Trauma, Antimicrobial Stewardship, Research, Clinical Practices, Infection Control, Military Health, Nosocomial Pathogen, Antibiotic Resistance, Retrospective Analysis, Prospectively Collected Data, Trauma Infectious Disease Outcomes Study, Clinical Outcomes, Infection Prevention, Military Medical Environments Hashtags: #wardocs #military #medicine #podcast #MilMed #MedEd #MilitaryMedicine, #PseudomonasAeruginosa, #CombatInfections, #InfectiousDiseases, #AntimicrobialStewardship, #WarDocsPodcast, #MilitaryHealthcare, #TraumaInfections, #InfectionPrevention, #ClinicalResearch   Honoring the Legacy and Preserving the History of Military Medicine   The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoD, and Our Nation.   Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast   Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm   WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you.   WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms.     Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast  

Dr Katie Savin joins Ethics Talk to discuss their article, coauthored with Drs Laura Guidry-Grimes and Olivia Kates: “What Does Disability Justice Require of Antimicrobial Stewardship?”  Recorded February 20, 2024.  Read the full article for free at JournalOfEthics.org

Drs Lynne Fehrenbacher and Leah Leonard-Kandarapally join Ethics Talk todiscuss key roles of infectious disease pharmacists and many clinicians in antimicrobial stewardship. Read the full June 2024 issue for free at JournalOfEthics.org

This presentation was delivered by Karin Thursky as part of the Cure stream at CODA22, which took place in Melbourne in September 2022.  For more information about the CODA Project go to: https://codachange.org/ 

Join special guest, Dr. Swati Gaur, and your host, Dr. Diane Sanders-Cepeda, for this special episode of FMDA's Journal Club, Antimicrobial Stewardship & Quality. This session focused on the following Learning Objectives: Revisit current guidance and protocols for Antimicrobial Stewardship in our PALTC facilities. Discuss how we are tackling vaccinations as it relates to COVID, Flu and RSV in our PALTC facilities for both residents and staff. Describe the challenges that PALTC facilities have with the spread of drug resistant pathogens such as Candida auris. Provide examples of interdisciplinary approaches to combatting the over prescribing of antibiotics and share how this impacts the quality of care for PALTC residents. Review how our PALTC Facilities can work with their QIO to educate and implement policies on Antimicrobial Stewardship. Recorded: February 14, 2024 Guest Panelists:  Amina Dubuisson, DNP, MBA/HCM, RN, LNHA, CDP; Deborah Franklin, MHA, NHA; and Toby Philpot Hosted by: Diane Sanders-Cepeda, DO, CMD Available Credit: The American Board of Post-Acute and Long-Term Care Medicine (ABPLM) issues CMD credits for AMDA On-The-Go and affiliate podcast episodes as follows: Claim CMD Credit

Today's episode of The SHEA Podcast discusses vancomycin and how antimicrobial stewardship programs should address its use. Our moderator is Mackenzie Keintz and our guests are Rebekah Moehring and Kimberly Claeys, two experts on the topic that represent the physician and pharmacy perspective of ASP programs. Listen as they discuss why vancomycin is a target for antimicrobial stewardship programs, strategies to target vancomycin use and safety, available alternatives, how to work with over prescribers, and lessons learned from our guests experiences targeting vancomycin use at their institution.

In this episode, MVC2024 speaker Dr. Christy King joins us to talk about renewed interest in antimicrobial resistance and share a sneak peek into programming from next month's conference. --- Send in a voice message: https://podcasters.spotify.com/pod/show/fully-vetted/message